Mid-Day Market Update: Aurinia Pharmaceuticals Gains On AURION Data; Twitter Shares Slide

Midway through trading Thursday, the Dow traded down 0.10 percent to 18,263.74 while the NASDAQ declined 0.12 percent to 5,309.47. The S&P also fell, dropping 0.03 percent to 2,160.42.

Leading and Lagging Sectors

On Thursday, non-cyclical consumer goods & services shares gained by 0.61 percent.

In trading on Thursday, healthcare shares tumbled by 0.46 percent. Meanwhile, top losers in the sector included Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ), down 47 percent, and The Medicines Company (NASDAQ: MDCO ), down 11 percent.

Top Headline

On Wednesday, Yum! Brands, Inc. (NYSE: YUM ) reported in-line earnings for its third quarter, but revenue missed estimates.

While EPS of $1.09 were in-line with the Street's consensus, revenue of $3.32 billion missed estimates by $200 million.

Equities Trading UP

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) shares shot up 34 percent to $5.43 after the company data from a 24-week clinical study called AURION, short for "Aurinia Early Urinary Protein Reduction Predicts Response Study." The open-label exploratory study consisted of 10 patients suffering from active lupus nephritisand and assessed the short-term predictors of response using the company's voclosporin (in a 23.7mg dose) in combination with mycophenolate mofetil (MMF) and oral corticosteroids. The study found that 70 percent of the patients achieved complete remission at 24 weeks.

Shares of Coupa Software Inc (NASDAQ: COUP ) got a boost, shooting up 89 percent to $34.09 in market debut. Coupa Software priced its IPO of 7.4 million shares at $18 per share.

Zumiez Inc. (NASDAQ: ZUMZ ) shares were also up, gaining 16 percent to $21.19. Zumiez reported an 11.5 percent rise in its Septmber sales and raised its Q3 revenue guidance.

Equities Trading DOWN

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) shares dropped 47 percent to $36.99 after the company disclosed that it has decided to discontinue the Revusiran development. Leerink Swann downgraded Alnylam Pharmaceuticals from Outperform to Market Perform and lowered the price target from $107.00 to $40.00, while Barclays also downgraded the stock from Overweight to Equal-weight and lowered the price target from $85.00 to $50.00.

Shares of Inventergy Global Inc (NASDAQ: INVT ) were down 33 percent to $0.830. Inventergy priced its 6 million share offering at $1 per share.

Twitter Inc (NYSE: TWTR ) was down, falling around 19 percent to $20.20 after Recode reported that Google (NASDAQ: GOOGL ), Apple Inc. (NASDAQ: AAPL ) and Walt Disney Co (NYSE: DIS ) are not interested in buying the social media company.


In commodity news, oil traded up 0.90 percent to $50.28 while gold traded down 0.86 percent to $1,257.70.

Silver traded down 1.92 percent Thursday to $17.36, while copper fell 0.65 percent to $2.15.


European shares were mostly lower today. The eurozone's STOXX 600 declined 0.40 percent, the Spanish Ibex Index fell 0.24 percent, while Italy's FTSE MIB Index gained 0.09 percent. Meanwhile the German DAX fell 0.16 percent, and the French CAC 40 declined 0.22 percent while U.K. shares fell 0.47 percent.


U.S. jobless claims declined 5,000 to 249,000 in the latest week. However, economists were expecting claims to reach 256,000 in the week.

Supplies of natural gas gained 80 billion cubic feet for the week ended September 30, the U.S. Energy Information Administration reported. Analysts expected a gain of 69 billion cubic feet.

Data on money supply for the recent week will be released at 4:30 p.m. ET.

© 2016 Benzinga does not provide investment advice. All rights reserved.

Profit with More New & Research . Gain access to a streaming platform with all the information you need to invest better today. Click here to start your 14 Day Trial of Benzinga Professional

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos